<DOC>
	<DOCNO>NCT01136369</DOCNO>
	<brief_summary>The study determine sensitivity , specificity , negative predictive value positive predictive value OSNA Breast Cancer System compare performance permanent section Hematoxylin Eosin ( H &amp; E ) IHC staining .</brief_summary>
	<brief_title>Clinical Evaluation OSNA Breast Cancer System Test Sentinel Lymph Nodes From Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>Male Female patient , age 18 , diagnose presurgically T1 T2 breast cancer schedule surgery include sentinel node dissection . Patients read understand inform consent form capable willing provide write informed consent . Patients diagnose presurgically large locally advanced ( T3 T4 ) breast cancer . Patients diagnose inflammatory breast cancer . Patients diagnose ductal carcinoma situ ( DCIS ) breast conserve do . Patients pregnant , confirm patient/treating physician interview . Patients suspicious palpable axillary lymph node . Patients currently treat previously diagnose , another type carcinoma . Patients undergone prior nononcologic breast surgery axillary surgery . Patients receive preoperative systemic therapy . Patients incapable provide write informed consent . Patients judged inappropriate medical care provider ( i.e . surgeon , oncologist , pathologist , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>metastasis</keyword>
	<keyword>molecular pathology</keyword>
</DOC>